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Abstract Mammalian prothymosin K, a small (12 kDa) and
extremely acidic protein (pI 3.5), is a member of the growing
family of ‘natively’ unfolded proteins. We demonstrate that at
low pH (V3) and high concentrations, prothymosin K is capable
of forming regular elongated fibrils with flat ribbon structure
4^5 nm in height and 12^13 nm in width as judged from
scanning force and electron microscopy. These aggregates
induced a characteristic spectral shift of thioflavin T fluores-
cence and their circular dichroism spectra were indicative of
significant L-sheet content, suggesting formation of classical
amyloid. Our findings indicate that natively unfolded proteins
may have a general propensity to form amyloid fibrils under
conditions inducing partially folded conformations. ß 2002
Published by Elsevier Science B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
A number of human diseases are accompanied by deposi-
tion of normally soluble proteins in the form of stable ¢brils
called amyloids [1^3] ; mature ¢brils and/or their precursors
are believed to have a pathogenic e¡ect. About 20 di¡erent
proteins have been found to be involved in various types of
amyloidoses, and most are related neither structurally nor at
the level of primary sequence. X-ray di¡raction data suggest
that all amyloid proteins form a cross-L structure, with con-
tinuous L-sheets running parallel and L-strands perpendicular
to the ¢ber axis [4,5]. Despite large di¡erences in the size of
aggregating peptides and proteins, ranging from 5 [6] to 415
[7] amino acids, the overall morphology of ¢brils is strikingly
common: all the ¢brils have similar diameter (6^12 nm) and
substructure, consisting of four to eight proto¢laments organ-
ized in a symmetric tubular or ribbon-like array [6,8,9]. It has
been suggested that the ability of a protein to form amyloid is
not determined by its sequence but rather re£ects a general
property of the protein backbone [10]. In support of this con-
clusion is the fact that several proteins not involved in
amyloidoses aggregate into ¢brils under certain conditions
[7,10^13]. In most cases, the aggregation process was induced
by partial unfolding of normally globular proteins, that is, by
maximizing the population of intermediate conformations
arising during the unfolding transition.
Here we report the formation of ¢brils by the ‘natively
unfolded’ protein prothymosin K (pTK). This 109 amino
acid-long protein is very acidic, containing V50% aspartic
and glutamic acid, no aromatic and sulfur residues, and
very few large hydrophobic aliphatic amino acids [14,15].
pTK adopts a random coil-like conformation with no regular
secondary structure, characteristic of the family of ‘natively
unfolded’ proteins [16,17]. An important member of this fam-
ily is K-synuclein, which forms ¢brillar aggregates, and whose
aggregation is associated with many neurodegenerative dis-
eases including Parkinson’s Disease [18,19]. We have found
that pTK aggregates into typical amyloid ¢brils under acidic
conditions that presumably decrease the repulsive intermolec-
ular forces caused by the high negative charge of the protein
at neutral pH and thereby induce its partial folding. pTK is
only the second known example of a natively unfolded protein
forming ¢brillar aggregates, and supports the argument that
the determinants of aggregation are the nature and population
of intermediate conformations in the folding^unfolding tran-
sitions.
2. Materials and methods
2.1. Protein puri¢cation and amyloid ¢brils formation
pTK was isolated from Escherichia coli BL21(DE3)/pHP12 (gift of
Dr. Alexandra Evsta¢eva) by a hot phenol extraction procedure [20],
further puri¢ed by anion exchange chromatography on a HiLoad
Q-Sepharose column (Amersham Pharmacia Biotech, Sweden), con-
centrated using Centricon-3 cartridges (Amicon, USA), and exten-
sively dialyzed against distilled water. There was no evidence of ag-
gregation in the resulting stock solution. For ¢brillization, 100^200 Wl
solutions of 1^5 mg/ml pTK in 100 mM glycine^HCl bu¡er, pH 2.5^
3.5, were incubated in glass bottles with stirring at 37 ‡C.
2.2. Circular dichroism (CD) spectroscopy
CD measurements were performed with a Jasco J715 spectropo-
larimeter. The CD spectra of samples diluted to a pTK concentration
of 8.3 WM (4 s response time, 50 nm/min scan rate, 7^20 scan aver-
ages) were obtained using a 1 mm pathlength cuvette. Experimental
data were converted to units of di¡erential molar circular dichroic
absorption. The spectra were deconvoluted using the CDPro software
package [21].
2.3. Fluorescence spectroscopy
Fluorescence measurements were made with a Cary Eclipse £uores-
cence spectrophotometer (Varian, Australia) in 100 Wl sample volume
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cuvettes, using excitation and emission slit widths of 5 nm. For the
thio£avin T (ThT) binding assay, a 1 Wl aliquot was withdrawn from
the ¢bril suspension/solution containing 100^333 WM pTK and added
to 100 Wl of freshly made 10 WM ThT solution (at pH 2.5 or 4.5). ThT
emission and excitation £uorescence spectra were obtained using
446 nm excitation (325 nm for the free dye) and emission at 480 nm
(465 nm for the free dye). The kinetics of ¢brillogenesis were followed
by measuring the ThT £uorescence emission at 480 nm using excita-
tion at 446 nm. For the 1-anilino-8-naphthalene sulfonate (ANS)
binding assay, a 1 Wl aliquot of the ¢bril solution was added to
100 Wl of 100 WM ANS solution containing 100 mM glycine^HCl,
pH 2.5. Emission spectra were recorded from 460 to 600 nm, using
370 nm excitation. The £uorescence emission maximum shifted from
520 nm to 485 nm during the course of the ¢brillization, and was used
to monitor the kinetics of the process.
2.4. Electron microscopy (EM)
A 1 Wl aliquot was taken from the reaction mixture, diluted 10-fold
in the incubation bu¡er, and immediately placed onto glow-dis-
charged carbon ¢lm as described [22]. After 2^5 min of adsorption,
the samples were rinsed with 2% aqueous uranyl acetate for 10^15 s
and blotted with a ¢lter paper. Where indicated, the samples were
unidirectionally shadowcast at an angle of 8‡ with tungsten, using
the electron gun of an Edwards Auto 306 apparatus. The samples
were examined with a CM12 electron microscope (Philips, The Neth-
erlands). Measurements of the micrographs were done using NIH
Image software modi¢ed for Windows (Scion Corporation, Frederick,
MD, USA)
2.5. Atomic force microscopy (AFM)
An aliquot from the ¢bril suspension was diluted with the incuba-
tion bu¡er and immediately deposited onto freshly cleaved mica
(W. Plannet GmbH, Germany), and imaged in tapping mode in a
£uid cell of the Nanoscope IIIa AFM (Digital Instruments, Santa
Barbara, CA, USA). A silicon nitride cantilever (NP-S, Digital Instru-
ments) with a force constant of 0.32 N/m was used at an oscillation
frequency of V8.4^8.8 kHz.
3. Results and discussion
Human pTK was produced in E. coli and puri¢ed by the hot
phenol extraction method developed by Evsta¢eva et al. [20],
which is based on the unique tendency of pTK to accumulate
in an aqueous phase rather than in an organic phase, like all
bacterial proteins. The protein was puri¢ed further by anion
exchange chromatography to more than 99% purity and
showed characteristic features reported previously [7,23,24].
Thus, in the course of gel-¢ltration chromatography, pTK
eluted as a protein with an apparent molecular mass of
58.4 þ 0.7 kDa (not shown); the molecular mass calculated
from its amino acid composition is 12 kDa. The CD spectrum
of the protein at pH 7.5 exhibited a minimum at 198 nm (Fig.
1A). Both experiments suggested that under neutral pH con-
ditions pTK exists in a random coil conformation. At pH 2.5
the shape of the CD spectrum changed, indicating the adop-
tion of K-helical conformation.
There was no evidence of further conformational perturba-
tions after prolonged incubation of 8.3 WM pTK under acidic
conditions. However, overnight incubation of the protein at
higher concentration (100^333 WM) in 100 mM glycine^HCl,
pH 2.5, at 37‡C resulted in a dramatic CD change, indicating
a predominant (V70%) L-strand conformation of the poly-
peptide chain (Fig. 1A). Such a behavior is characteristic for
the formation of amyloid ¢brils that have high L-strand con-
tent. The rate of ¢bril formation increased with the concen-
tration of the incubated protein.
Further evidence of pTK ¢brillization was obtained with a
ThT binding assay. It is known that most amyloids induce a
strong red shift of the ThT £uorescence excitation spectrum
and increase the £uorescence quantum yield of the dye [25];
pTK aggregates demonstrated these properties very clearly
(Fig. 1B). Since it has been suggested that the apparent a⁄n-
ity for ThT decreases with lower pH due to the quaternary
positively charged benzothiazole ring nitrogen [26], a pHv 6
is normally used for ThT binding. We indeed observed a ¢ve-
fold increase of £uorescence intensity at 480 nm (using exci-
tation at 446 nm) for ¢brils studied at pH 4.5 compared to
pH 2.5 (not shown). However, despite the lower sensitivity, we
performed £uorescence assays at pH 2.5 in order to preserve
conditions optimal for ¢brillization.
We further analyzed the morphology of the aggregates,
which showed a high signal in the ThT assay, by means of
transmission EM and scanning force microscopy. Both tech-
niques showed the presence of amyloid ¢brils of lengthsV50^
500 nm with similar structures, although minor di¡erences
could be discerned (Fig. 2). From the images of negatively
stained samples it was clear that ¢brils were not uniform in
width; i.e. some short regions were narrower (V5 nm) than
the typical width (V11 nm) of the majority of the ¢brils.
Sometimes these narrow segments were clustered, with a pe-
riodicity of V100 nm (Fig. 2A). Unidirectionally shadowed
samples showed that the height of the ¢brils was not uniform
(Fig. 2B). That is, the height was generally V4^5 nm,
Fig. 1. CD spectra of pTK and £uorescence spectra of bound ThT.
A: CD spectrum at protein concentration 8.3 WM, pH 7.5 (solid
line), and pH 2.5 (short-dashed line). Protein concentration, 333 WM
in 100 mM glycine^HCl, pH 2.5, after overnight incubation at 37‡C
with stirring (long-dashed line). B: Fluorescence excitation and
emission spectra of 10 WM ThT in the presence of pTK aggregates
(solid line) and of free 10 mM ThT (short-dashed line).
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although a strong modulation from 4^5 to 11^13 nm was
clearly seen with a period of V120 nm. We conclude that
the ¢brils exhibited a £at ribbon structure,V4^5 nm in height
and V11^13 nm in width. Modulations in width or height
were most probably due to twist of the ¢brils. SFM imaging
revealed a minimal height of ¢brils of V4^6 nm consistent
with the values determined by EM. However, contrary to EM
data, segments with approximately double height had a sig-
ni¢cantly wider appearance (Fig. 2C). The di¡erent morphol-
ogies observed depended on the conditions and imaging tech-
nique.
The time course of pTK ¢brillization at pH 2.5 was moni-
tored simultaneously with several techniques (Fig. 3A). Both
ThT and ANS £uorescence, as well as CD at 218 nm (a mea-
sure of L-strand content) demonstrated a sigmoidal time de-
pendence with a lag phase characteristic of nucleation-depen-
dent processes. All methods yielded almost coincidental signal
progressions suggesting that the various signals detected syn-
chronously arising features. In contrast, turbidity measure-
ments showed a delayed response, most likely related to the
formation of larger aggregates (not shown). CD spectra col-
Fig. 2. Structure of pTK ¢brils. A: Transmission electron micro-
graph of negatively stained sample. Arrowheads indicate narrow
regions of ¢brils; inset, magni¢ed view of ¢bril segment with modu-
lated width. B: Transmission electron micrograph of unidirectionally
shadowed sample. Arrowheads indicate regions of ¢brils with
increased height. C: Scanning force microscopy image (height).
Arrowheads indicate regions of ¢brils with increased height and
width. Color bar, height 30 nm. Scale bars, 100 nm.
Fig. 3. Kinetics of pTK ¢brillization. A: ThT binding assay (R),
ANS binding assay (E) and molar ellipticity at 218 nm (h). All mea-
sures are given in relative units. B: Far-UV CD spectra of pTK ac-
quired during the course of ¢brillization as a function of incubation
time (curves increasing in number). Spectra 1^10 were acquired after
15, 75, 135, 165, 195, 225, 255, 285, 315, and 345 min of incubation
respectively. Read spectra from bottom to top (i.e. spectrum 10 cor-
responds to the longest incubation time), except for spectra 1 and 2,
which correspond to 15 and 75 min of incubation, respectively.
Fig. 4. Kinetics of pTK ¢brillization assessed by ThT binding assay.
pH 2.5 (E), pH 3 (O), and pH 3.5 (a).
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lected during ¢brillization exhibited an isodichroic intersection
at 212 nm, suggesting a two-state transition of pTK from a
partially folded to the L-strand conformation (Fig. 3B).
Fibrils formed by pTK demonstrated high sensitivity to pH,
being fairly stable upon increasing pH up to 4.5 but immedi-
ately breaking down at pH 5. The ability to ¢brillize was
inhibited at even lower pH (Fig. 4). It has been reported
previously that pTK partially folds under acidic conditions,
demonstrating a sigmoidal pH dependence of K-helicity with
a midpoint at pH 4.4 [24]. It was hypothesized that the struc-
ture of the folding product (10% K-helix at pH 2.4) represents
the premolten globule (compact denatured) state, based on
decreased hydrodynamic volume of the protein and enhance-
ment of ANS £uorescence indicative of solvent exposed hy-
drophobic clusters.
We hypothesize that the extreme instability of pTK ¢brils at
pHs 4.5 originates from strong repulsive forces between neg-
atively charged molecules, which also account for the total
unfolding of isolated protein molecules. It is also possible
that the pTK ¢brillogenic behavior at pHV3 is facilitated
by the transformation of a random coil into a partially folded
conformation characterized by the presence of hydrophobic
patches and lack of rigid tertiary structure. At high pTK con-
centration these properties could favor both hydrophobic and
hydrogen bond-mediated intermolecular contacts and lead to
the formation of oligomers slowly transforming into the
L-strand-rich nuclei required for amyloid formation.
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